Have you considered using Symlin or Byetta?
No, but I do know what they are
No, and I don't know what they are
Yes, and I am using Symlin
Yes, and I am using Byetta
Yes, I tried Symlin but stopped using it
Yes, I tried Byetta but stopped using it
Yes, but I've considered Symlin but I haven't decided or started yet
Yes, but I've considered Byetta but I haven't decided or started yet
Total votes: 378
Have you considered using Symlin or Byetta?Poll dates: June 17 - 24, 2007
Total Votes: 378
Symlin® and Byetta® are two new drugs for treating type 1 (Symlin) and type 2 (Symlin and Byetta) diabetes. Symlin is particularly interesting for adults and older teens with type 1 diabetes because it has been shown to reduce post-prandial glucose spikes, to reduce overall glucose excursions, and to help with weight loss. Byetta has similar effects in patients with type 2 diabetes.
Given the growing awareness of the importance of reducing the variability of glucose levels, such as post-prandial spikes, Symlin may prove to be one of the most important treatment advances in quite some time for people with type 1 diabetes. It's worth discussing Symlin with your diabetes team if you are an adult or older teen with type 1 diabetes.
At present (June 2007), Symlin is FDA approved for adults 18 years or older with type 1 or type 2 diabetes. Byetta is FDA approved for adults 18 or older with type 2 diabetes. Use of Symlin in people under 18 is off label.
Symlin is approved only for injection and according to the labeling is not to be mixed with insulin. However, one study found essentially no effect on control when Symlin was mixed with a rapid acting insulin and immediately injected. And while Symlin is not approved for use in an insulin pump (i.e., an insulin pump dedicated just to delivering Symlin), we know several adults with type 1 diabetes who wear two insulin pumps -- one for insulin and one for Symlin. Mixing with insulin and use in an insulin pump are both off label and should be discussed with your diabetes team.
Compared with last year's poll on this topic, awareness of Symlin and Byetta has increased (30% know about the medications now versus 20% last year).
Both Symlin and Byetta are from Amylin Pharmaceuticals, Inc., based in San Diego, California.
Symlin is currently available only in vials (June 2007)
Byetta comes in two different strength pens
Last Updated: Sunday June 24, 2007 07:54:54
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.